3.3.0.814 html 118 225 1 false 45 0 false 4 false false R1.htm 101 - Document - Document and Entity Information Sheet http://www.merrimackpharma.com/taxonomy/role/DocumentandEntityInformation Document and Entity Information Cover 1 false false R2.htm 103 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.merrimackpharma.com/taxonomy/role/StatementOfFinancialPositionClassified Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 104 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.merrimackpharma.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 105 - Statement - Condensed Consolidated Statements of Comprehensive Loss Sheet http://www.merrimackpharma.com/taxonomy/role/StatementOfOtherComprehensiveIncome Condensed Consolidated Statements of Comprehensive Loss Statements 4 false false R5.htm 106 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.merrimackpharma.com/taxonomy/role/StatementOfCashFlowsIndirect Condensed Consolidated Statements of Cash Flows Statements 5 false false R6.htm 107 - Disclosure - Nature of the Business Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsNatureOfOperations Nature of the Business Notes 6 false false R7.htm 108 - Disclosure - Basis of Presentation and Consolidation Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock Basis of Presentation and Consolidation Notes 7 false false R8.htm 109 - Disclosure - Net Loss Per Common Share Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock Net Loss Per Common Share Notes 8 false false R9.htm 110 - Disclosure - License and Collaboration Agreements Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock License and Collaboration Agreements Notes 9 false false R10.htm 111 - Disclosure - Fair Value of Financial Instruments Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock Fair Value of Financial Instruments Notes 10 false false R11.htm 112 - Disclosure - Accounts Payable, Accrued Expenses and Other Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock Accounts Payable, Accrued Expenses and Other Notes 11 false false R12.htm 113 - Disclosure - Borrowings Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock Borrowings Notes 12 false false R13.htm 114 - Disclosure - Common Stock Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock Common Stock Notes 13 false false R14.htm 115 - Disclosure - Stock-Based Compensation Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock Stock-Based Compensation Notes 14 false false R15.htm 116 - Disclosure - Recent Accounting Pronouncements Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock Recent Accounting Pronouncements Notes 15 false false R16.htm 117 - Disclosure - Subsequent Events Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsSubsequentEventsTextBlock Subsequent Events Notes 16 false false R17.htm 118 - Disclosure - Recent Accounting Pronouncements (Policies) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlockPolicies Recent Accounting Pronouncements (Policies) Policies http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsNewAccountingPronouncementsAndChangesInAccountingPrinciplesTextBlock 17 false false R18.htm 119 - Disclosure - Basis of Presentation and Consolidation (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlockTables Basis of Presentation and Consolidation (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsOrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock 18 false false R19.htm 120 - Disclosure - Net Loss Per Common Share (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables Net Loss Per Common Share (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock 19 false false R20.htm 121 - Disclosure - License and Collaboration Agreements (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlockTables License and Collaboration Agreements (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsCollaborativeArrangementDisclosureTextBlock 20 false false R21.htm 122 - Disclosure - Fair Value of Financial Instruments (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlockTables Fair Value of Financial Instruments (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock 21 false false R22.htm 123 - Disclosure - Accounts Payable, Accrued Expenses and Other (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlockTables Accounts Payable, Accrued Expenses and Other (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsAccountsPayableAndAccruedLiabilitiesDisclosureTextBlock 22 false false R23.htm 124 - Disclosure - Borrowings (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlockTables Borrowings (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock 23 false false R24.htm 125 - Disclosure - Common Stock (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables Common Stock (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock 24 false false R25.htm 126 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlockTables Stock-Based Compensation (Tables) Tables http://www.merrimackpharma.com/taxonomy/role/NotesToFinancialStatementsDisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock 25 false false R26.htm 127 - Disclosure - Basis of Presentation and Consolidation - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureBasisOfPresentationAndConsolidationAdditionalInformation Basis of Presentation and Consolidation - Additional Information (Detail) Details 26 false false R27.htm 128 - Disclosure - Basis of Presentation and Consolidation - Schedule of Non-Controlling Interest in Subsidiary (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureBasisOfPresentationAndConsolidationScheduleOfNonControllingInterestInSubsidiary Basis of Presentation and Consolidation - Schedule of Non-Controlling Interest in Subsidiary (Detail) Details 27 false false R28.htm 129 - Disclosure - Net Loss Per Common Share - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureNetLossPerCommonShareAdditionalInformation Net Loss Per Common Share - Additional Information (Detail) Details 28 false false R29.htm 130 - Disclosure - Net Loss Per Common Share - Schedule of Potentially Dilutive Securities Excluded from Computation of Diluted Weighted Average Shares (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureNetLossPerCommonShareScheduleOfPotentiallyDilutiveSecuritiesExcludedFromComputationOfDilutedWeightedAverageShares Net Loss Per Common Share - Schedule of Potentially Dilutive Securities Excluded from Computation of Diluted Weighted Average Shares (Detail) Details 29 false false R30.htm 131 - Disclosure - License and Collaboration Agreements - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureLicenseAndCollaborationAgreementsAdditionalInformation License and Collaboration Agreements - Additional Information (Detail) Details 30 false false R31.htm 132 - Disclosure - License and Collaboration Agreements - Schedule of Revenue Recognized and Assets and Liabilities under Collaborative Arrangements (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureLicenseAndCollaborationAgreementsScheduleOfRevenueRecognizedAndAssetsAndLiabilitiesUnderCollaborativeArrangements License and Collaboration Agreements - Schedule of Revenue Recognized and Assets and Liabilities under Collaborative Arrangements (Detail) Details 31 false false R32.htm 133 - Disclosure - Fair Value of Financial Instruments - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsScheduleOfAssetsAndLiabilitiesMeasuredAtFairValueOnARecurringBasis Fair Value of Financial Instruments - Schedule of Assets and Liabilities Measured at Fair Value on a Recurring Basis (Detail) Details 32 false false R33.htm 134 - Disclosure - Fair Value of Financial Instruments - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureFairValueOfFinancialInstrumentsAdditionalInformation Fair Value of Financial Instruments - Additional Information (Detail) Details 33 false false R34.htm 135 - Disclosure - Accounts Payable, Accrued Expenses and Other - Schedule of Accounts Payable, Accrued Expenses and Other (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureAccountsPayableAccruedExpensesAndOtherScheduleOfAccountsPayableAccruedExpensesAndOther Accounts Payable, Accrued Expenses and Other - Schedule of Accounts Payable, Accrued Expenses and Other (Detail) Details 34 false false R35.htm 136 - Disclosure - Borrowings - Schedule of Future Minimum Payments under the Loans Payable (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureBorrowingsScheduleOfFutureMinimumPaymentsUnderTheLoansPayable Borrowings - Schedule of Future Minimum Payments under the Loans Payable (Detail) Details 35 false false R36.htm 137 - Disclosure - Borrowings - 4.50% Convertible Senior Notes - Additional Information (Detail) Notes http://www.merrimackpharma.com/taxonomy/role/DisclosureBorrowings450ConvertibleSeniorNotesAdditionalInformation Borrowings - 4.50% Convertible Senior Notes - Additional Information (Detail) Details 36 false false R37.htm 138 - Disclosure - Borrowings - Loan Agreement - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureBorrowingsLoanAgreementAdditionalInformation Borrowings - Loan Agreement - Additional Information (Detail) Details 37 false false R38.htm 139 - Disclosure - Common Stock - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureCommonStockAdditionalInformation Common Stock - Additional Information (Detail) Details 38 false false R39.htm 140 - Disclosure - Common Stock - Schedule of Shares Reserved for Future Issuance (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureCommonStockScheduleOfSharesReservedForFutureIssuance Common Stock - Schedule of Shares Reserved for Future Issuance (Detail) Details 39 false false R40.htm 141 - Disclosure - Stock-Based Compensation - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureStockBasedCompensationAdditionalInformation Stock-Based Compensation - Additional Information (Detail) Details 40 false false R41.htm 142 - Disclosure - Stock-Based Compensation - Schedule of Assumptions Used to Calculate Fair Value of Options Granted to Employees and Directors (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureStockBasedCompensationScheduleOfAssumptionsUsedToCalculateFairValueOfOptionsGrantedToEmployeesAndDirectors Stock-Based Compensation - Schedule of Assumptions Used to Calculate Fair Value of Options Granted to Employees and Directors (Detail) Details 41 false false R42.htm 143 - Disclosure - Stock-Based Compensation - Schedule of Recognized Stock-Based Compensation Expense (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureStockBasedCompensationScheduleOfRecognizedStockBasedCompensationExpense Stock-Based Compensation - Schedule of Recognized Stock-Based Compensation Expense (Detail) Details 42 false false R43.htm 144 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureStockBasedCompensationSummaryOfStockOptionActivity Stock-Based Compensation - Summary of Stock Option Activity (Detail) Details 43 false false R44.htm 145 - Disclosure - Subsequent Events - Additional Information (Detail) Sheet http://www.merrimackpharma.com/taxonomy/role/DisclosureSubsequentEventsAdditionalInformation Subsequent Events - Additional Information (Detail) Details 44 false false All Reports Book All Reports In ''Condensed Consolidated Balance Sheets'', column(s) 3, 4 are contained in other reports, so were removed by flow through suppression. In ''Condensed Consolidated Statements of Cash Flows'', column(s) 1, 2 are contained in other reports, so were removed by flow through suppression. mack-20150930.xml mack-20150930_cal.xml mack-20150930_def.xml mack-20150930_lab.xml mack-20150930_pre.xml mack-20150930.xsd true true